Preclinical News and Research

RSS
University at Albany researcher receives $1.76 million NIH grant to explore role of vitamin D in breast cancer

University at Albany researcher receives $1.76 million NIH grant to explore role of vitamin D in breast cancer

Study can help spur beneficial lifestyle changes in patients to reduce Alzheimer's risk

Study can help spur beneficial lifestyle changes in patients to reduce Alzheimer's risk

Cytokinetics, The ALS Association expand partnership to fight against ALS

Cytokinetics, The ALS Association expand partnership to fight against ALS

Profil Institute for Clinical Research forms strategic partnership with Gubra

Profil Institute for Clinical Research forms strategic partnership with Gubra

Scientists uncover why some people more prone to major depression

Scientists uncover why some people more prone to major depression

MR Solutions provides advanced preclinical imaging solution at Manchester University

MR Solutions provides advanced preclinical imaging solution at Manchester University

BioLife reports increased use of CryoStor and HypoThermosol biopreservation media products in clinical studies

BioLife reports increased use of CryoStor and HypoThermosol biopreservation media products in clinical studies

Takara Bio Europe launches Cellartis DEF-CS Xeno-Free Culture Medium for iPS cell culture

Takara Bio Europe launches Cellartis DEF-CS Xeno-Free Culture Medium for iPS cell culture

Leica Microsystems to acquire OCT company Bioptigen

Leica Microsystems to acquire OCT company Bioptigen

MorphoSys' MOR202 proprietary drug candidate meets primary endpoints in multiple myeloma patients

MorphoSys' MOR202 proprietary drug candidate meets primary endpoints in multiple myeloma patients

ASCO 2015: Berg presents data from BPM 31510 Phase Ib trial for solid tumors

ASCO 2015: Berg presents data from BPM 31510 Phase Ib trial for solid tumors

Experimental drug and common antibiotic combination holds promise for pancreatic cancer treatment

Experimental drug and common antibiotic combination holds promise for pancreatic cancer treatment

Stable IV formulation to treat systemic susceptible and resistant Gram-positive hospital-acquired infections

Stable IV formulation to treat systemic susceptible and resistant Gram-positive hospital-acquired infections

Novartis CTL019 CAR T cell therapy demonstrates potential to treat B-cell lymphomas

Novartis CTL019 CAR T cell therapy demonstrates potential to treat B-cell lymphomas

Genticel announces positive results of new multivalent HPV therapeutic vaccine based on Vaxiclase platform

Genticel announces positive results of new multivalent HPV therapeutic vaccine based on Vaxiclase platform

LaunchPad receives exclusive worldwide license for bone adhesive technology from Stryker

LaunchPad receives exclusive worldwide license for bone adhesive technology from Stryker

Poster related to Cantex's lead compound CX-01 presented at ASCO 2015

Poster related to Cantex's lead compound CX-01 presented at ASCO 2015

Esperance announces positive results from EP-100 Phase II trial in paclitaxel-resistant ovarian cancer

Esperance announces positive results from EP-100 Phase II trial in paclitaxel-resistant ovarian cancer

University of Southampton and BioInvent enter collaboration to develop new cancer immunotherapies

University of Southampton and BioInvent enter collaboration to develop new cancer immunotherapies

Combination of nivolumab and ipilimumab drugs can improve outcomes in patients with advanced melanoma

Combination of nivolumab and ipilimumab drugs can improve outcomes in patients with advanced melanoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.